https://ambergen.com/wp-content/uploads/2016/11/logo-retina-300x71.png00Annmarie Thompsonhttps://ambergen.com/wp-content/uploads/2016/11/logo-retina-300x71.pngAnnmarie Thompson2016-09-27 13:27:082016-09-27 13:27:08AmberGen awarded 3-year Phase II SBIR grant from NIH-NIGMS to develop Bead-AMS™ for screening on- and off-target drug binding on a proteome-wide scale